Amanote Research
Register
Sign In
P1.01-77 Osimertinib in the First-Line Treatment of Non-Small Cell Lung Cancer Harboring Activating EGFR Mutation From Circulating Tumor DNA
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.633
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
C. Park
H. Cho
Y.D. Choi
I. Oh
Y. Kim
Publisher
Elsevier BV